Cabaletta Bio, Inc.CABANASDAQ
LOADING
|||
R&D Expense Growth Accelerating
Trending higher, above historical average.
Left:
||||
Year-over-year research & development expense growth
Latest
75.38%
↑ 39% above average
Average (7y)
54.22%
Historical baseline
Range
High:161.27%
Low:0.00%
Volatility
297.4%
High variability
| Period | Value |
|---|---|
| 2024 | 75.38% |
| 2023 | 41.03% |
| 2022 | 20.95% |
| 2021 | 52.01% |
| 2020 | 83.15% |
| 2019 | 161.27% |
| 2018 | 0.00% |
| 2017 | 0.00% |